Annihilare Medical Systems announced that it filed a non-provisional patent application for hypochlorous disinfecting wipes in April. The disinfecting wipe is poised to be the first of its kind in the industry. The combination of solution and substrate will enable the product to offer one of the safest, most effective wipes in the marketplace.

“After over two years of scouring the industry to find the proper substrate material for hypochlorous acid wipes, we realized that it wasn’t available and further innovation would be required,” states Marty Paris, founder and CEO of Annihilare.

Berry Global is manufacturing the wipe material for Annihilare.

“In an age where hospitals are still buying or making more toxic bleach wipes for daily use, we can now offer a more effective, safer, and more efficient system for eradicating hospital acquired infections, including C. diff,” says Paris. “The combination of our onsite generation technology and the dry chargeable wipes brings this solution to the market very quickly. Customers will also experience less supply chain issues and a dramatic reduction in furniture damage and replacement costs.”

Roll out for the disinfecting wipes program will be at the AHE conference in Orlando, and ISSA in Chicago, both in October. The EPA-registered, consumer packaged pre-saturated wipes products will launch in 2023.